Morgan Stanley Downgrades Ultragenyx Pharma (RARE) to Equalweight

September 3, 2026 1:05 PM

Morgan Stanley analyst Maxwell Skor downgraded Ultragenyx Pharma (NASDAQ: RARE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found